This is a Validated Antibody Database (VAD) review about human HLA E, based on 11 published articles (read how Labome selects the articles), using HLA E antibody in all methods. It is aimed to help Labome visitors find the most suited HLA E antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HLA E synonym: HLA-6.2; QA1

BioLegend
mouse monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 1d
BioLegend HLA E antibody (BioLegend, 3D12) was used in flow cytometry on human samples (fig 1d). BMC Immunol (2019) ncbi
mouse monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 2c
BioLegend HLA E antibody (BioLegend, 3D12) was used in flow cytometry on human samples (fig 2c). Blood (2019) ncbi
mouse monoclonal (3D12)
  • immunohistochemistry - frozen section; human; loading ...; fig 4a, 4c
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a, 4c
BioLegend HLA E antibody (BioLegend, 342602) was used in immunohistochemistry - frozen section on human samples (fig 4a, 4c) and in immunohistochemistry - paraffin section on human samples (fig 4a, 4c). Cell (2018) ncbi
mouse monoclonal (3D12)
  • flow cytometry; human; fig 6
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend HLA E antibody (Biolegend, 3D12) was used in flow cytometry on human samples (fig 6). Mucosal Immunol (2016) ncbi
mouse monoclonal (3D12)
  • flow cytometry; human
BioLegend HLA E antibody (Biolegend, 3D12) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
Invitrogen
mouse monoclonal (3D12HLA-E)
  • flow cytometry; human; loading ...; fig s3a
Invitrogen HLA E antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig s3a). Front Immunol (2018) ncbi
mouse monoclonal (3D12HLA-E)
  • flow cytometry; human
Invitrogen HLA E antibody (eBioscience, 3D12HLA-E) was used in flow cytometry on human samples . J Immunol (2014) ncbi
Bio-Rad
mouse monoclonal (MEM-E/02)
  • immunohistochemistry - paraffin section; human; 1:200
Bio-Rad HLA E antibody (Serotec, MEM-E/02) was used in immunohistochemistry - paraffin section on human samples at 1:200. Int J Cancer (2014) ncbi
Abcam
mouse monoclonal (W6/32)
  • flow cytometry; human; fig 8
Abcam HLA E antibody (Abcam, W6/32) was used in flow cytometry on human samples (fig 8). Sci Rep (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (MEM-E/02)
  • immunohistochemistry - paraffin section; human; fig St1B
Santa Cruz Biotechnology HLA E antibody (Santa Cruz, sc-51621) was used in immunohistochemistry - paraffin section on human samples (fig St1B). Breast Cancer Res Treat (2015) ncbi
Abnova
mouse monoclonal (MEM-E/02)
  • immunohistochemistry; human; fig 1
Abnova HLA E antibody (Abnova, MAB0939) was used in immunohistochemistry on human samples (fig 1). Cell Immunol (2015) ncbi
Exbio
mouse monoclonal (MEM-E/02)
  • immunohistochemistry - paraffin section; human; 1 ug/ml; loading ...; fig s4
Exbio HLA E antibody (Exbio, MEM-E/02) was used in immunohistochemistry - paraffin section on human samples at 1 ug/ml (fig s4). Cell (2018) ncbi
Articles Reviewed
  1. Tremblay McLean A, Coenraads S, Kiani Z, Dupuy F, Bernard N. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function. BMC Immunol. 2019;20:8 pubmed publisher
  2. Hallner A, Bernson E, Hussein B, Sander F, Brune M, Aurelius J, et al. The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia. Blood. 2019;: pubmed publisher
  3. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  4. Mahaweni N, Ehlers F, Sarkar S, Janssen J, Tilanus M, Bos G, et al. NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment. Front Immunol. 2018;9:1415 pubmed publisher
  5. Müller M, Wasson C, Bhatia R, Boxall S, Millan D, Goh G, et al. YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins. Sci Rep. 2015;5:12523 pubmed publisher
  6. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  7. Engels C, Charehbili A, van de Velde C, Bastiaannet E, Sajet A, Putter H, et al. The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis. Breast Cancer Res Treat. 2015;149:587-96 pubmed publisher
  8. Guo Z, Lv Y, Wang L, Shi S, Yang F, Zheng G, et al. Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients. Cell Immunol. 2015;293:10-6 pubmed publisher
  9. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  10. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher
  11. van Esch E, Tummers B, Baartmans V, Osse E, Ter Haar N, Trietsch M, et al. Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy. Int J Cancer. 2014;135:830-42 pubmed publisher